Nrx pharmaceuticals (nasdaq:nrxp) publishes shareholder update letter

Potential paths to revenue and profitability in 2025 radnor, pa. , july 1, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that the company posted a new shareholder update letter on its website nrx shareholder update and further invites interested parties to subscribe to their email alert service to stay up to date on company's progress here: nrx email alerts.
NRXP Ratings Summary
NRXP Quant Ranking